Related Experiment Videos
Surgery for mucin-producing pancreatic tumor
1First Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
Hepato-Gastroenterology
|February 10, 1999
Summary
Surgical techniques for mucin-producing pancreatic tumors vary, with function-preserving methods like pylorus-preserving pancreaticoduodenectomy (PPPD) offering better outcomes than total pancreatectomy. Careful surgical technique is crucial to avoid complications from pancreatic duct mucus leakage.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Pancreatic Pathology
Background:
- Diverse mucin-producing pancreatic tumors exist, including benign adenoma and malignant types.
- Surgical treatment strategies for these tumors are not well-established.
- Intraductal papillary carcinoma and invasive papillary carcinoma are key malignant subtypes.
Purpose of the Study:
- To evaluate surgical techniques for mucin-producing pancreatic tumors.
- To analyze surgical outcomes and patient post-operative courses.
- To compare prognoses based on surgical interventions.
Main Methods:
- Retrospective analysis of 24 patients undergoing surgery for mucin-producing pancreatic tumors (August 1981-December 1997).
- Detailed documentation of surgical procedures, including total pancreatectomy, Whipple's procedure, pylorus-preserving pancreaticoduodenectomy (PPPD), and duodenum-preserving pancreatic head resection (DPPHR).
- Assessment of post-operative complications, survival rates, and recurrence patterns.
Main Results:
- Surgical resection was successful in 23 patients, employing various techniques.
- The 5-year survival rate for malignant tumors was 68.4%.
- No intraoperative or immediate postoperative fatalities occurred; one transient complication of duodenal stenosis was noted.
Conclusions:
- Surgically resectable mucin-producing pancreatic tumors have a better prognosis than invasive pancreatic duct carcinoma.
- Function-preserving surgeries (PPPD, DPPHR, segmentectomy) are preferred when feasible.
- Total pancreatectomy is reserved for extensive pancreatic invasion or positive margins; avoiding pancreatic duct mucus leakage during surgery is critical.